In Your Best Interests
Our teams deliver coordinated legal advice to support you in doing business in an international context.
Stay informed
We keep you up to date on all major legal news, nationally and internationally.
Our teams deliver coordinated legal advice to support you in doing business in an international context.
We keep you up to date on all major legal news, nationally and internationally.
On 1 August 2022, not only the annual national holiday could be celebrated extensively in Switzerland. Particularly noteworthy is also the entry into force of the new requirements for the regulation of medical cannabis.
Cannabis was qualified as a prohibited narcotic in Switzerland until the end of summer 2022 – without further specification in relation to a medical application. Accordingly, the cultivation, importation, production, and marketing of cannabis required an exemption permit from the Federal Office of Public Health (FOPH).
More
The European Data Protection Board (hereafter ‘EDPB’) has published Guidelines for the calculation of fines under the General Data Protection Regulation (GDPR). In this part 5 of a series of six articles, we will go through the amount of fines when the turnover is up to €500 million in the previous financial year and more than €500 million in the previous financial year, the notion of “undertaking”, its corporate liability, the Akzo presumption, the determination of the turnover and to whom in an undertaking a fine is addressed.
More
Just in time for summer, the miniseries «How to Change Your Mind» will be launched in July on the Netflix streaming platform. In this documentary series, author Michael Pollan and Co. analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years[1]. The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Switzerland is a leader in the research and use of psychedelics in psychiatry and is considered an innovation driver in this field. Nevertheless, the regulatory hurdles for researchers and patients are still extremely high. In this article we elaborate on the requirements under which psychedelics may be used in Switzerland today.
More
The European Data Protection Board (hereafter ‘EDPB’) has published Guidelines for the calculation of fines under the General Data Protection Regulation (GDPR). The supervisory authority retains the discretion to utilize the full fining range of GDPR fines from a point above € 0,- until the legal maximum, ensuring that the GDPR fine is tailored to the circumstances of the case. The categories for starting amounts of GDPR fines serve as starting points for further calculation of the fines and do not limit the supervisory authorities’ abilities to take into account aggravating and mitigating circumstances to an amount above or below the categories for starting amounts of GDPR fines. In this part 4 of a series of six articles, we will go through how the supervisory authority must consider the aggravating, neutral and mitigating factors (as listed in Article 83(2) GDPR,) for the further calculation of the GDPR fine.
More
26 September 2021 marks a historical turning point in terms of rights for the LGBTIQ+ community. On that day, Swiss citizens said yes to “marriage for all”, following developments in neighboring countries in recent years.
MoreThis website cannot be displayed correctly because you are using Internet Explorer. For optimal viewing and security, please use Chrome, Firefox or Edge.
